Abstract

Naltrexone Hydrochloride 50-mg Capsules

Author(s): Allen Loyd V Jr

Issue: May/Jun 2013 - Volume 17, Number 3

Page(s): 235

Download in electronic PDF format for $75

Abstract

A formulation for preparing Naltrexone Hydrochloride 50-mg Capsules. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2013 Pg. 235	Naltrexone Hydrochloride 50-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 233	Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 157-162	Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Morris Tommy C, Graves Richard A
Jan/Feb 2000 Pg. 17-20	Opioids: A Review of the Pharmacology Author(s): Ford Peter R
Jul/Aug 2009 Pg. 296-299	Compounding Naltrexone for the Treatment of Autism Author(s): Wynn Tom, Brunetti Sarah
Sep/Oct 2021 Pg. 372-377	Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Author(s): Riepl Mike
May/Jun 2018 Pg. 252-256	The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia Author(s): Cote Brianna, Ross Bethany, Fortner Jeff, Rao Deepa
May/Jun 2013 Pg. 233	Labetalol 50-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 67	Naltrexone Hydrochloride 1.4-mg/mL Injection, Preservative Free Author(s): Allen Loyd V Jr
Jul/Aug 1999 Pg. 291-294	The Basics of Compounding: Compounding Special Capsules Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 274-275	Chemical Stability of Naltrexone Hydrochloride Injection Author(s): Gupta Vishnu D
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2018 Pg. 270-278	Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Author(s): Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Sep/Oct 2005 Pg. 391	Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 12.5-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 392	Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 25-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 197-201	Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Author(s): Sturn Kayla M, Collin Michael
Sep/Oct 2003 Pg. 389-393	Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Author(s): Alexander Kenneth S, Thyangarajapuram N
Sep/Oct 2022 Pg. 364-368	A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Author(s): Riepl Mike